World Investment Advisors’s United Therapeutics UTHR Stock Holding History

World Investment Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$563K	Buy	949 +1	+0.1%	+$563	0.01%	910
2026 Q1	$562K	Sell	948 -106	-10%	-$52.8K	0.01%	925
2025 Q4	$514K	Sell	1,054 -1	-0.1%	-$466	0.01%	920
2025 Q3	$442K	Sell	1,055 -338	-24%	-$114K	0.01%	828
2025 Q2	$400K	Sell	1,393 -935	-40%	-$279K	0.01%	805
2025 Q1	$718K	Buy	2,328 +1,029	+79%	+$353K	0.02%	590
2024 Q4	$458K	Buy	1,299 +202	+18%	+$74.2K	0.01%	685
2024 Q3	$393K	Buy	+1,097	New	+$371K	0.01%	653

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

World Investment Advisors's UTHR Position: Q2 2026 in Review

World Investment Advisors increased its United Therapeutics (UTHR) stake by 0.11% in Q2 2026, buying an estimated $563 and bringing the position to 949 shares worth $563K. The position accounts for 0.01% of the portfolio, ranked #910.

World Investment Advisors first reported a position in UTHR in Q3 2024 and has held it in 8 quarters since. The position peaked at $718K in Q1 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

World Investment Advisors held 949 shares of United Therapeutics worth $563K as of Q2 2026.
World Investment Advisors bought 1 United Therapeutics share in Q2 2026, an estimated $563.
United Therapeutics made up 0.01% of World Investment Advisors's portfolio in Q2 2026, its #910 holding.
World Investment Advisors first reported a position in United Therapeutics in Q3 2024 and has held it in 8 quarters since.
World Investment Advisors's United Therapeutics position peaked at $718K in Q1 2025.
884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on World Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.